Viewing Study NCT01931306


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-02-24 @ 12:25 AM
Study NCT ID: NCT01931306
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2018-11-14
First Post: 2013-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module